Cargando…

Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China

BACKGROUND: Data concerning adherence to hepatocellular carcinoma (HCC) surveillance among chronic liver disease (CLD) patients at high risk of developing HCC in China are limited. We aimed to examine the relationship between HCC-related knowledge dimensions and adherence to HCC surveillance procedu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Jingyi, Zhao, Jun, Du, Yingrong, Zhuang, Lin, McNeil, Edward B, Chongsuvivatwong, Virasakdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434375/
https://www.ncbi.nlm.nih.gov/pubmed/32884337
http://dx.doi.org/10.2147/CMAR.S259195
_version_ 1783572133433049088
author Dai, Jingyi
Zhao, Jun
Du, Yingrong
Zhuang, Lin
McNeil, Edward B
Chongsuvivatwong, Virasakdi
author_facet Dai, Jingyi
Zhao, Jun
Du, Yingrong
Zhuang, Lin
McNeil, Edward B
Chongsuvivatwong, Virasakdi
author_sort Dai, Jingyi
collection PubMed
description BACKGROUND: Data concerning adherence to hepatocellular carcinoma (HCC) surveillance among chronic liver disease (CLD) patients at high risk of developing HCC in China are limited. We aimed to examine the relationship between HCC-related knowledge dimensions and adherence to HCC surveillance procedures among chronic liver disease patients at high risk of developing HCC and to identify potential barriers. METHODS: A total of 380 patients with chronic liver disease at high risk of developing HCC were recruited between May and August 2018 to complete a survey during the first week of their first hospitalization at the Third People’s Hospital of Kunming in China. We followed up each patient up to 7 months by telephone to confirm whether the patient returned to complete investigations for HCC surveillance. Patient’s socio-demographic characteristics, HCC-related knowledge, and perceived barriers to HCC surveillance were measured using a structured questionnaire during their hospitalization. Factor analysis was performed on the knowledge questions to reduce the dimensions. Univariate and multivariate analyses were performed to examine the association between dimensions of HCC-related knowledge and patients’ adherence to HCC surveillance. RESULTS: A total of 327 eligible patients had been successfully contacted in the follow-up phase. Only a quarter of patients completed HCC surveillance within 7 months after their first admission to hospital. High costs and perceived poor test efficacy were the two major barriers for HCC surveillance. Three common factors were derived from the factor analysis of HCC-related knowledge, namely, “Surveillance”, “Lifestyle”, and ‘Prognosis’. Knowledge of HCC surveillance and lifestyle but not prognosis had an influence on adherence to HCC surveillance. Patients with better surveillance and lifestyle knowledge domain had better adherence to HCC surveillance. CONCLUSION: Adherence to HCC surveillance procedures is low in the study area. Closing the gap in HCC-related knowledge, particularly regarding surveillance and lifestyle, may help to increase adherence rates.
format Online
Article
Text
id pubmed-7434375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74343752020-09-02 Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China Dai, Jingyi Zhao, Jun Du, Yingrong Zhuang, Lin McNeil, Edward B Chongsuvivatwong, Virasakdi Cancer Manag Res Original Research BACKGROUND: Data concerning adherence to hepatocellular carcinoma (HCC) surveillance among chronic liver disease (CLD) patients at high risk of developing HCC in China are limited. We aimed to examine the relationship between HCC-related knowledge dimensions and adherence to HCC surveillance procedures among chronic liver disease patients at high risk of developing HCC and to identify potential barriers. METHODS: A total of 380 patients with chronic liver disease at high risk of developing HCC were recruited between May and August 2018 to complete a survey during the first week of their first hospitalization at the Third People’s Hospital of Kunming in China. We followed up each patient up to 7 months by telephone to confirm whether the patient returned to complete investigations for HCC surveillance. Patient’s socio-demographic characteristics, HCC-related knowledge, and perceived barriers to HCC surveillance were measured using a structured questionnaire during their hospitalization. Factor analysis was performed on the knowledge questions to reduce the dimensions. Univariate and multivariate analyses were performed to examine the association between dimensions of HCC-related knowledge and patients’ adherence to HCC surveillance. RESULTS: A total of 327 eligible patients had been successfully contacted in the follow-up phase. Only a quarter of patients completed HCC surveillance within 7 months after their first admission to hospital. High costs and perceived poor test efficacy were the two major barriers for HCC surveillance. Three common factors were derived from the factor analysis of HCC-related knowledge, namely, “Surveillance”, “Lifestyle”, and ‘Prognosis’. Knowledge of HCC surveillance and lifestyle but not prognosis had an influence on adherence to HCC surveillance. Patients with better surveillance and lifestyle knowledge domain had better adherence to HCC surveillance. CONCLUSION: Adherence to HCC surveillance procedures is low in the study area. Closing the gap in HCC-related knowledge, particularly regarding surveillance and lifestyle, may help to increase adherence rates. Dove 2020-07-23 /pmc/articles/PMC7434375/ /pubmed/32884337 http://dx.doi.org/10.2147/CMAR.S259195 Text en © 2020 Dai et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Dai, Jingyi
Zhao, Jun
Du, Yingrong
Zhuang, Lin
McNeil, Edward B
Chongsuvivatwong, Virasakdi
Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
title Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
title_full Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
title_fullStr Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
title_full_unstemmed Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
title_short Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China
title_sort adherence to hepatocellular carcinoma surveillance and perceived barriers among high-risk chronic liver disease patients in yunnan, china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434375/
https://www.ncbi.nlm.nih.gov/pubmed/32884337
http://dx.doi.org/10.2147/CMAR.S259195
work_keys_str_mv AT daijingyi adherencetohepatocellularcarcinomasurveillanceandperceivedbarriersamonghighriskchronicliverdiseasepatientsinyunnanchina
AT zhaojun adherencetohepatocellularcarcinomasurveillanceandperceivedbarriersamonghighriskchronicliverdiseasepatientsinyunnanchina
AT duyingrong adherencetohepatocellularcarcinomasurveillanceandperceivedbarriersamonghighriskchronicliverdiseasepatientsinyunnanchina
AT zhuanglin adherencetohepatocellularcarcinomasurveillanceandperceivedbarriersamonghighriskchronicliverdiseasepatientsinyunnanchina
AT mcneiledwardb adherencetohepatocellularcarcinomasurveillanceandperceivedbarriersamonghighriskchronicliverdiseasepatientsinyunnanchina
AT chongsuvivatwongvirasakdi adherencetohepatocellularcarcinomasurveillanceandperceivedbarriersamonghighriskchronicliverdiseasepatientsinyunnanchina